Submissions from 2025
“Diabetes and Kidneys: Unraveling T2D’s Silent Threat”, Radica Alicic
“Diabetes and Kidneys: Unraveling T2D’s Silent Threat”, Radica Alicic
Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 2013-2020., Radica Z Alicic, Obidiugwu K Duru, Cami R Jones, Lindsey M Kornowske, Kenn B Daratha, Christina L Reynolds, Meda E Pavkov, Alain K Koyama, Fang Xu, Susanne B Nicholas, Joshua J Neumiller, Keith C Norris, Kelly A Hennessey, and Katherine R Tuttle
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease., Radica Z Alicic, Joshua J Neumiller, and Katherine R Tuttle
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6., Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, Johannes F E Mann, Søren Rasmussen, Peter Rossing, Katherine R Tuttle, Blaz Vrhnjak, and Hiddo J L Heerspink
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials., Ellen M Apperloo, Katherine Tuttle, Imre Pavo, Axel Haupt, Rebecca Taylor, Russell J Wiese, Andrea Hemmingway, David Z I Cherney, Naveed Sattar, and Hiddo J L Heerspink
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials., Ellen M Apperloo, Katherine Tuttle, Imre Pavo, Axel Haupt, Rebecca Taylor, Russell J Wiese, Andrea Hemmingway, David Z I Cherney, Naveed Sattar, and Hiddo J L Heerspink
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials., Sunil V Badve, Anika Bilal, Matthew M Y Lee, Naveed Sattar, Hertzel C Gerstein, Christian T Ruff, John J V McMurray, Peter Rossing, George Bakris, Kenneth W Mahaffey, Johannes F E Mann, Helen M Colhoun, Katherine Tuttle, Richard E Pratley, and Vlado Perkovic
Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease., Thelma Barber, Joshua J Neumiller, Michelle A Fravel, Robert L Page, and Katherine R Tuttle
Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study., Dominic Ehrmann, Heidi Krause-Steinrauf, Diane Uschner, Hui Wen, Claire J Hoogendoorn, Gladys Crespo-Ramos, Caroline Presley, Valerie L Arends, Robert M Cohen, W Timothy Garvey, Thomas Martens, Holly J Willis, Andrea Cherrington, Jeffrey S Gonzalez, GRADE Research Group, Frances E. Broyles, and Warren L. Fein
Continuous glucose monitoring improves detection of glycemic excursions in hemodialysis patients with type 2 diabetes., Rodolfo J Galindo, Bobak Moazzami, Amany Gerges, Ina Flores, Giuliana Arevalo, Limin Peng, Katherine R Tuttle, and Guillermo E Umpierrez
Pilot Study of Plasma miRNA Signature Panel for Differentiating Single vs Multiglandular Parathyroid Disease., Melanie Goldfarb, Matias A Bustos, Jamie Moon, Katherine Jackson, Frederick R Singer, and Dave S B Hoon
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial., Hiddo J L Heerspink, Rajiv Agarwal, George L Bakris, David Z I Cherney, Carolyn S P Lam, Brendon L Neuen, Pantelis A Sarafidis, Katherine R Tuttle, Christoph Wanner, Meike D Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, and FIND-CKD investigators
Impact of weight change on kidney transplantation outcomes: A systematic review and meta-analysis., Mehmet Kanbay, Dimitrie Siriopol, Sama Mahmoud Abdel-Rahman, Zeynep Y Yilmaz, Lasin Ozbek, Mustafa Guldan, Sidar Copur, and Katherine Tuttle
Glycemic Management and Individualized Diabetes Care in Dialysis-Dependent Kidney Failure., Klara R Klein, Ildiko Lingvay, Katherine R Tuttle, and Jennifer E Flythe
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Prevalence and clinical characteristics of patients with hsCRP testing and test-confirmed systemic inflammation among individuals with atherosclerotic cardiovascular disease with or without chronic kidney disease in the United States (PLUTUS)., Lei Lv, Jigar Rajpura, Meixia Liu, Matt Strum, Benjamin Chastek, Jonathan Johnson, and Tyler J Gluckman
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial., Kenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, Florian M M Baeres, George Bakris, David M Charytan, David Z I Cherney, Gil Chernin, Ricardo Correa-Rotter, Janusz Gumprecht, Thomas Idorn, Giuseppe Pugliese, Ida Kirstine Bull Rasmussen, Søren Rasmussen, Peter Rossing, Ekaterina Sokareva, Johannes F E Mann, Vlado Perkovic, and Richard Pratley
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial., Mahmoud B Malas, Mohammed Hamouda, Alik Farber, Matthew T Menard, Michael S Conte, Kenneth Rosenfield, Michael B Strong, Gheorghe Doros, Richard J Powell, Carlos Mena-Hurtado, Warren Gasper, Marc L Schermerhorn, Sara Allievi, Kim G Smolderen, Michael D Dake, Jennifer A Rymer, and Katherine Tuttle
Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk., Rozalina G McCoy, Kavya Sindhu Swarna, Joshua J Neumiller, Eric C Polley, Yihong Deng, Mindy M Mickelson, and Jeph Herrin
Extending Kidney Protective Therapy to Type 1 Diabetes: The Time is Now., Joshua J Neumiller and Katherine R Tuttle
Long-term efficacy of 10 kHz spinal cord stimulation in managing painful diabetic neuropathy: A post-study survey., Erika A Petersen, Shawn M Sills, Thomas G Stauss, Rose Province-Azalde, Michael J Jaasma, Deborah R Edgar, Judith L White, James A Scowcroft, Cong Yu, Jijun Xu, Maged N Guirguis, Kasra Amirdelfan, David J DiBenedetto, Ali Nairizi, Shivanand P Lad, Neel D Mehta, Dawood Sayed, Khalid A Sethi, Sarah Benducci, and Manish Bharara
Outcomes Of Patients With Advanced Chronic Kidney Disease And A Pulmonary Artery Pressure Sensor: Insights From The HF2 Registry, Mason Sanders, Elizabeth Volz, Kartik Munshi, Terrie Ann Benjamin, Mosi Bennett, Pranathi Pilla, Kunjan Bhatt, Arvind Bhimaraj, Timothy Fendler, Marat Fudim, Maya Guglin, Ashrith Guha, J. Thomas Heywood, Orvar Jonsson, Liviu Klein, Patrick McCann, Monique Robinson, Andrew Sauer, Hsin-Fang Li, Hirak Shah, and Jacob Abraham
Indications and outcomes of the extended endoscopic endonasal approach for the removal of "unconventional" suprasellar pituitary neuroendocrine tumors., Domenico Solari, Elena d'Avella, Garni Barkhoudarian, Matteo Zoli, Stephanie Cheok, Ilaria Bove, Gianluca Lorenzo Fabozzi, Gabriel Zada, Diego Mazzatenta, Daniel F Kelly, Paolo Cappabianca, and Luigi Maria Cavallo
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease., Vikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, Ni Huajing, Sebastien O Lanctot, David M Maahs, Petter Bjornstad, M Luiza Caramori, Sylvia E Rosas, Peter Rossing, Katherine R Tuttle, Rodica Pop-Busui, Sarit Polsky, Amy B Karger, Chunyi Wu, Andrzej T Galecki, Bruce A Perkins, Michael Mauer, Alessandro Doria, and David Z I Cherney
Adding New Agents to Treatment Protocols for Patients with CKD, Katherine Tuttle
Adding New Agents to Treatment Protocols for Patients with CKD, Katherine Tuttle
“Celebrating Dr. Steven Packer with those who know him well”, Katherine Tuttle
“Celebrating Dr. Steven Packer with those who know him well”, Katherine Tuttle
GLP 1 Receptor Agonism FLOWS into the Mainstream for Chronic Kidney Disease, Katherine Tuttle
GLP 1 Receptor Agonism FLOWS into the Mainstream for Chronic Kidney Disease, Katherine Tuttle
“Goal for Saving Kidneys, Hearts and Lives”, Katherine Tuttle
“Goal for Saving Kidneys, Hearts and Lives”, Katherine Tuttle
Interview with Katherine Tuttle and Jonathan Barratt, Katherine Tuttle
Interview with Katherine Tuttle and Jonathan Barratt, Katherine Tuttle
Outcomes of Critical Limb Threatening Ischemia Revascularization in Patients with Chronic Kidney Disease in the BEST - CLI Trial, Katherine Tuttle
Outcomes of Critical Limb Threatening Ischemia Revascularization in Patients with Chronic Kidney Disease in the BEST - CLI Trial, Katherine Tuttle
The Link between CKD and CVD, Katherine Tuttle
The Link between CKD and CVD, Katherine Tuttle
“Transforming CKD Care”, Katherine Tuttle
“Transforming CKD Care”, Katherine Tuttle
Feasibility for Utilization of Assessment for Lack of Protective Sensation as Part of a Foot Screening for Persons with Intellectual Disabilities., Montana Von Musser, Hannah McCulley, and David Jenkins
State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease., Kirk M Welker, David Joyner, Anthony W Kam, David S Liebeskind, Amit M Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi, and John E Jordan
Submissions from 2024
“GLP-1 Ras: On the Mechanisms of Renoprotection”, Radica Alicic
Role of GLP-1 and GIP/GLP-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions, Radica Alicic and JJ Neumiller
Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6., Ellen M Apperloo, David Z I Cherney, Anja Birk Kuhlman, Johannes F E Mann, Søren Rasmussen, Peter Rossing, Katherine Tuttle, Blaz Vrhnjak, and Hiddo J L Heerspink
Pre-Prediabetes: Insulin Resistance is Associated with Cardiometabolic Risk in Non-obese Patients (STOP DIABETES)., John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, and Ron Ruby
Can Artificial Intelligence Be Utilized to Predict Real-Time Adverse Outcomes in Individuals Arriving at the Emergency Department With Hyperglycemic Crises?: Implications for APRN Practice., Alisha Amin Bhimani, Tova Safier Frenkel, and Adam Kaizer Hasham
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial., Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine Tuttle, Samy Hadjadj, and Peter Rossing
Dietary intake and continuous blood glucose measurement in nurses working either 12-hour day shifts or night shifts, Rachel Carlson, Teresa Rangel, Lindsey Miller, and Sushana Sudhi
New and emerging therapies for diabetic kidney disease., Ricardo Correa-Rotter, Louise J Maple-Brown, Rakesh Sahay, Katherine R Tuttle, and Ifeoma I Ulasi
Diabetic Kidney Disease Prevention Care Model Development., Nuha A ElSayed, Raveendhara R Bannuru, George Bakris, Joan Bardsley, Ian H de Boer, Robert A Gabbay, Janet Gockerman, Rozalina G McCoy, Elaine McCracken, Joshua J Neumiller, Scott J Pilla, and Connie M Rhee
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and Writing team and the World Kidney Day Joint Steering Committee
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and World Kidney Day Joint Steering Committee
Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis., Rodolfo J Galindo, Bobak Moazzami, Katherine R Tuttle, Richard M Bergenstal, Limin Peng, and Guillermo E Umpierrez
In the Heat of the Moment: Thermal Ablation for "All Things Thyroid"., Melanie Goldfarb
Pilot study of plasma miRNA signature panel for differentiating single vs multiglandular parathyroid disease., Melanie Goldfarb, Matias A Bustos, Jamie Moon, Katherine M Jackson, Frederick R Singer, and Dave Hoon
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial., Hiddo J L Heerspink, Vlado Perkovic, Katherine R Tuttle, Pablo E Pergola, Kenneth W Mahaffey, Uptal D Patel, Julie H Ishida, Albert Kuo, Fang Chen, Robert Kustra, Vladimir Petrovic, Peter Rossing, Naoki Kashihara, and Glenn M Chertow
Impacts of Tocolytics on Maternal and Neonatal Glucose Levels in Women With Gestational Diabetes Mellitus., Subeen Hong, Hyun-Joo Seol, JoonHo Lee, Han Sung Hwang, Ji-Hee Sung, Ji Young Kwon, Seung Mi Lee, Won Joon Seong, Soo Ran Choi, Seung Chul Kim, Hee-Sun Kim, Se Jin Lee, Sae-Kyung Choi, Kyung A Lee, Hyun Sun Ko, and Hyun Soo Park
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial., Parminder K Judge, Katherine Tuttle, Natalie Staplin, Sibylle J Hauske, Doreen Zhu, Rebecca Sardell, Lisa Cronin, Jennifer B Green, Nikita Agrawal, Ryoki Arimoto, Kaitlin J Mayne, Emily Sammons, Martina Brueckmann, Shimoli V Shah, Peter Rossing, Masaomi Nangaku, Martin J Landray, Christoph Wanner, Colin Baigent, Richard Haynes, and William G Herrington
Multi-omic Profiling in a 61 day Pig Kidney to Human Decedent Xenotransplant Reveals a Concerted Acute Rejection Immune Response, B Keating, Brian Piening, and See full list of authors in comments
Development and Validation of the American Heart Association's PREVENT Equations., Sadiya S Khan, Kunihiro Matsushita, Yingying Sang, Shoshana H Ballew, Morgan E Grams, Aditya Surapaneni, Michael J Blaha, April P Carson, Alexander R Chang, Elizabeth Ciemins, Alan S Go, Orlando M Gutierrez, Shih-Jen Hwang, Simerjot K Jassal, Csaba P Kovesdy, Donald M Lloyd-Jones, Michael G Shlipak, Latha P Palaniappan, Laurence Sperling, Salim S Virani, Katherine Tuttle, Ian J Neeland, Sheryl L Chow, Janani Rangaswami, Michael J Pencina, Chiadi E Ndumele, Josef Coresh, and Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
Maternal and Neonatal Outcomes Based on Changes in Glycosylated Hemoglobin Levels During First and Second Trimesters of Pregnancy in Women with Pregestational Diabetes: Multicenter, Retrospective Cohort Study in South Korea., Mi Ju Kim, Suyeon Park, Sooran Choi, Subeen Hong, Ji-Hee Sung, Hyun-Joo Seol, Joon Ho Lee, Seung Cheol Kim, Sae-Kyoung Choi, Ji Young Kwon, Seung Mi Lee, Se Jin Lee, Han-Sung Hwang, Gi Su Lee, Hyun Soo Park, Soo-Jeong Lee, Geum Joon Cho, Jin-Gon Bae, Won Joon Seong, and Hyun Sun Ko
KIAA0753 enhances osteoblast differentiation suppressed by diabetes., Mengxue Li, Yongqin Wang, Xiangmei Wu, Quanmei Chen, Jianguo Huang, Huifang Zhu, Shengyong Yang, Jichun Wang, Le Tai Li, Xianjun Liu, Kang Fu, Fangzhou Song, and Changdong Wang
Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease., Christine P Limonte, Julio A Lamprea-Montealegre, and Katherine Tuttle
Artificial intelligence-enabled electrocardiography contributes to hyperthyroidism detection and outcome prediction., Chin Lin, Feng-Chih Kuo, Tom Chau, Jui-Hu Shih, Chin-Sheng Lin, Chien-Chou Chen, Chia-Cheng Lee, and Shih-Hua Lin
Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?, Valerie A Luyckx, Ayah Elmaghrabi, Manisha Sahay, Nicole Scholes-Robertson, Laura Sola, Tobias Speare, Elliot K Tannor, Katherine Tuttle, and Ikechi G Okpechi
Mind the Gap in Kidney Care: Translating What We Know Into What We Do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the Gap in Kidney Care: Translating What We Know Into What We do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the Gap in Kidney Care: Translating What We Know into What We Do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Mind the Gap in Kidney Care: Translating What We Know into What We Do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston Ws Fung, Ágnes Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the Gap in Kidney Care: Translating What We Know Into What We Do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and The World Kidney Day Joint Steering Committee is listed in the Appendix
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Mind the gap in kidney care: translating what we know into what we do., V A Luyckx, Katherine Tuttle, D Abdellatif, R Correa-Rotter, W W S Fung, A Haris, L L Hsiao, M Khalife, L A Kumaraswami, F Loud, V Raghavan, S Roumeliotis, M Sierra, I Ulasi, B Wang, S F Lui, V Liakopoulos, and A Balducci
Prevalence and clinical characteristics of US patients with systemic inflammation and atherosclerotic cardiovascular disease with or without chronic kidney disease, Lei Lv, Ty Gluckman, and See full list of authors in comments
Prevalence of high-sensitivity C-reactive protein testing among US patients with atherosclerotic cardiovascular disease with or without chronic kidney disease, Lei Lv, Jigar Rajpura, Matt Strum, and Tyler J Gluckman
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial., Johannes F E Mann, Peter Rossing, George Bakris, Nicolas Belmar, Heidrun Bosch-Traberg, Robert Busch, David M Charytan, Samy Hadjadj, Pieter Gillard, José Luis Górriz, Thomas Idorn, Linong Ji, Kenneth W Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland E Schmieder, Richard E Pratley, and Katherine Tuttle
Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial., Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Emily Sammons, David Zi Cherney, Alfred K Cheung, Aldo P Maggioni, Masaomi Nangaku, Xavier Rossello, Katherine Tuttle, Katsuhito Ihara, Tomoko Iwata, Christoph Wanner, Jonathan Emberson, David Preiss, Martin J Landray, Colin Baigent FMedSci, Richard Haynes, and William G Herrington
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD., Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD., Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study., Yuichiro Mori, Toshiaki Komura, Motohiko Adomi, Ryuichiro Yagi, Shingo Fukuma, Naoki Kondo, Motoko Yanagita, O Kenrik Duru, Katherine Tuttle, and Kosuke Inoue
Insulin Icodec., Matthew Nelson
Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease., Brendon L Neuen, Katherine Tuttle, and Muthiah Vaduganathan
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Semaglutide for Chronic Kidney Disease in Type 2 Diabetes. Reply., Vlado Perkovic, Katherine Tuttle, and Richard Pratley
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes., Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Kenneth W Mahaffey, Johannes F E Mann, George Bakris, Florian M M Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, Richard Pratley, and FLOW Trial Committees and Investigators
